UBS Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-7,301
| Closed | -$42.6K | – | 9918 |
|
2022
Q4 | $42.6K | Sell |
7,301
-6,560
| -47% | -$38.3K | ﹤0.01% | 5757 |
|
2022
Q3 | $94K | Buy |
13,861
+4,142
| +43% | +$28.1K | ﹤0.01% | 4710 |
|
2022
Q2 | $41K | Sell |
9,719
-6,347
| -40% | -$26.8K | ﹤0.01% | 5065 |
|
2022
Q1 | $54K | Sell |
16,066
-2,383
| -13% | -$8.01K | ﹤0.01% | 5405 |
|
2021
Q4 | $58K | Sell |
18,449
-10,216
| -36% | -$32.1K | ﹤0.01% | 5682 |
|
2021
Q3 | $94K | Buy |
28,665
+3,121
| +12% | +$10.2K | ﹤0.01% | 4795 |
|
2021
Q2 | $108K | Sell |
25,544
-11,981
| -32% | -$50.7K | ﹤0.01% | 4786 |
|
2021
Q1 | $188K | Buy |
37,525
+782
| +2% | +$3.92K | ﹤0.01% | 4563 |
|
2020
Q4 | $465K | Buy |
36,743
+2,519
| +7% | +$31.9K | ﹤0.01% | 3735 |
|
2020
Q3 | $336K | Sell |
34,224
-17,332
| -34% | -$170K | ﹤0.01% | 3674 |
|
2020
Q2 | $513K | Sell |
51,556
-7,397
| -13% | -$73.6K | ﹤0.01% | 3369 |
|
2020
Q1 | $521K | Sell |
58,953
-19,676
| -25% | -$174K | ﹤0.01% | 3173 |
|
2019
Q4 | $726K | Sell |
78,629
-3,279
| -4% | -$30.3K | ﹤0.01% | 3605 |
|
2019
Q3 | $482K | Buy |
81,908
+14,084
| +21% | +$82.9K | ﹤0.01% | 3753 |
|
2019
Q2 | $814K | Buy |
67,824
+5,643
| +9% | +$67.7K | ﹤0.01% | 3192 |
|
2019
Q1 | $751K | Buy |
62,181
+2,245
| +4% | +$27.1K | ﹤0.01% | 3105 |
|
2018
Q4 | $752K | Sell |
59,936
-17,040
| -22% | -$214K | ﹤0.01% | 3206 |
|
2018
Q3 | $1.14M | Sell |
76,976
-212
| -0.3% | -$3.15K | ﹤0.01% | 3041 |
|
2018
Q2 | $1.3M | Sell |
77,188
-48,660
| -39% | -$819K | ﹤0.01% | 2871 |
|
2018
Q1 | $2.88M | Sell |
125,848
-167,006
| -57% | -$3.82M | ﹤0.01% | 2264 |
|
2017
Q4 | $7.58M | Buy |
292,854
+34,420
| +13% | +$890K | ﹤0.01% | 1531 |
|
2017
Q3 | $3.81M | Buy |
258,434
+160,449
| +164% | +$2.37M | ﹤0.01% | 1968 |
|
2017
Q2 | $1.37M | Sell |
97,985
-16,081
| -14% | -$224K | ﹤0.01% | 2691 |
|
2017
Q1 | $1.95M | Sell |
114,066
-62,385
| -35% | -$1.06M | ﹤0.01% | 2370 |
|
2016
Q4 | $1.82M | Sell |
176,451
-4,124
| -2% | -$42.4K | ﹤0.01% | 2350 |
|
2016
Q3 | $1.83M | Sell |
180,575
-38,617
| -18% | -$390K | ﹤0.01% | 2299 |
|
2016
Q2 | $2.46M | Sell |
219,192
-11,446
| -5% | -$129K | ﹤0.01% | 2037 |
|
2016
Q1 | $3.15M | Sell |
230,638
-16,877
| -7% | -$231K | ﹤0.01% | 1803 |
|
2015
Q4 | $4.7M | Sell |
247,515
-33,059
| -12% | -$627K | ﹤0.01% | 1567 |
|
2015
Q3 | $5.27M | Sell |
280,574
-2,224
| -0.8% | -$41.7K | ﹤0.01% | 1445 |
|
2015
Q2 | $4.21M | Sell |
282,798
-3,001
| -1% | -$44.7K | ﹤0.01% | 1742 |
|
2015
Q1 | $4.33M | Buy |
285,799
+13,779
| +5% | +$209K | ﹤0.01% | 1729 |
|
2014
Q4 | $3.62M | Buy |
+272,020
| New | +$3.62M | ﹤0.01% | 1815 |
|